Molecular fingerprints of cardiovascular toxicities of immune checkpoint inhibitors
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Molecular fingerprints of cardiovascular toxicities of immune checkpoint inhibitors ; day:17 ; month:7 ; year:2024 ; pages:1-19
Basic research in cardiology ; (17.7.2024), 1-19
- Urheber
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s00395-024-01068-8
- URN
-
urn:nbn:de:101:1-2410080806009.568484397578
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:38 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Gergely, Tamás G.
- Drobni, Zsófia D.
- Sayour, Nabil V.
- Ferdinandy, Péter
- Varga, Zoltán V.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Risk Factors for Immune Checkpoint Inhibitor–Mediated Cardiovascular Toxicities
Imaging Features of Toxicities by Immune Checkpoint Inhibitors in Cancer Therapy
Cardiovascular Toxicity of Immune Checkpoint Inhibitors: A Guide for Clinicians
Methylated Organic Metabolites of Arsenic and their Cardiovascular Toxicities
A retrospective analysis of cardiovascular adverse events associated with immune checkpoint inhibitors
Managing toxicities associated with immune checkpoint inhibitors: consensus recommendations from the Society for Immunotherapy of Cancer (SITC) Toxicity Management Working Group
Case report: a successful treatment with immune checkpoint inhibitors was associated with severe dermatologic toxicities in a patient with double primary malignancies
Neurosarcoidosis following Immune Checkpoint Inhibition
Immune Checkpoint Inhibitor Rechallenge After Prior Immune Toxicity
Immune checkpoint analysis in lip cancer
Immune checkpoint inhibitor-related acral vasculitis
Immune checkpoint blockade in ovarian cancer
Risk Factors for Immune Checkpoint Inhibitor–Mediated Cardiovascular Toxicities
Imaging Features of Toxicities by Immune Checkpoint Inhibitors in Cancer Therapy
Cardiovascular Toxicity of Immune Checkpoint Inhibitors: A Guide for Clinicians
Methylated Organic Metabolites of Arsenic and their Cardiovascular Toxicities
A retrospective analysis of cardiovascular adverse events associated with immune checkpoint inhibitors
Managing toxicities associated with immune checkpoint inhibitors: consensus recommendations from the Society for Immunotherapy of Cancer (SITC) Toxicity Management Working Group
Case report: a successful treatment with immune checkpoint inhibitors was associated with severe dermatologic toxicities in a patient with double primary malignancies
Neurosarcoidosis following Immune Checkpoint Inhibition
Immune Checkpoint Inhibitor Rechallenge After Prior Immune Toxicity
Immune checkpoint analysis in lip cancer
Immune checkpoint inhibitor-related acral vasculitis
Immune checkpoint blockade in ovarian cancer
Risk Factors for Immune Checkpoint Inhibitor–Mediated Cardiovascular Toxicities
Imaging Features of Toxicities by Immune Checkpoint Inhibitors in Cancer Therapy
Cardiovascular Toxicity of Immune Checkpoint Inhibitors: A Guide for Clinicians
Methylated Organic Metabolites of Arsenic and their Cardiovascular Toxicities
A retrospective analysis of cardiovascular adverse events associated with immune checkpoint inhibitors
Managing toxicities associated with immune checkpoint inhibitors: consensus recommendations from the Society for Immunotherapy of Cancer (SITC) Toxicity Management Working Group
Case report: a successful treatment with immune checkpoint inhibitors was associated with severe dermatologic toxicities in a patient with double primary malignancies
Neurosarcoidosis following Immune Checkpoint Inhibition
Immune Checkpoint Inhibitor Rechallenge After Prior Immune Toxicity
Immune checkpoint analysis in lip cancer
Immune checkpoint inhibitor-related acral vasculitis